E
Alaunos Therapeutics, Inc. TCRT
$1.46 -$0.02-1.35%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

09/30/2024 06/30/2024 03/31/2024 12/31/2023 09/30/2023
Net Income 86.70% 87.14% 83.26% 14.37% 4.24%
Total Depreciation and Amortization -100.00% -99.86% -99.71% -65.27% -1.74%
Total Amortization of Deferred Charges -- -- -- -100.00% -100.00%
Total Other Non-Cash Items -96.23% -93.26% -83.19% 413.89% 131.37%
Change in Net Operating Assets 137.95% 49.85% 73.16% -241.42% -180.76%
Cash from Operations 87.75% 75.99% 79.57% -3.58% -3.73%
Capital Expenditure -- -- -- 100.00% 92.86%
Sale of Property, Plant, and Equipment -- -- -- 6,434.78% --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -- -- -- -- --
Cash from Investing -- -- -- 1,716.13% 107.14%
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- 100.00% 100.00%
Issuance of Common Stock -- -- -- -100.00% -100.00%
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash from Financing -- -- -- -100.00% 100.00%
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 87.75% 91.21% 87.68% -570.18% 22.90%
Weiss Ratings